Cel AI PLC
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLAI.L research report →
Companywww.getcel.ai
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online.
- CEO
- Michael Scott Edwards
- IPO
- 2021
- Employees
- 1
- HQ
- London, GB
Price Chart
Valuation
- Market Cap
- $815.13K
- P/E
- -0.41
- P/S
- 45.43
- P/B
- 1.46
- EV/EBITDA
- -0.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 57.18%
- Op Margin
- -10305.32%
- Net Margin
- -10185.38%
- ROE
- -131.60%
- ROIC
- -359.34%
Growth & Income
- Revenue
- $17.94K · -73.31%
- Net Income
- $-1,827,461 · 44.79%
- EPS
- $-0.00 · 51.61%
- Op Income
- $-1,848,981
- FCF YoY
- 42.84%
Performance & Tape
- 52W High
- $0.94
- 52W Low
- $0.03
- 50D MA
- $0.23
- 200D MA
- $0.24
- Beta
- 0.36
- Avg Volume
- 79.95M
Get TickerSpark's AI analysis on CLAI.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CLAI.L Coverage
We haven't published any research on CLAI.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLAI.L Report →